EC4 Real-World Healthcare Costs in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the United States
Abstract
Authors
F. Laliberte M. Raut G. Germain K. Desai A. Nahar X. Yang S. MacKnight M.S. Duh